EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25320013.
- Also identified by DOI 10.1158/0008-5472.CAN-13-2994.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
MT4-MMP (MMP-17) is a glycosylphosphatidyl inositol-anchored matrix metalloprotease expressed on the surface of cancer cells that promotes tumor growth and metastasis. In this report, we identify MT4-MMP as an important driver of cancer cell proliferation through CDK4 activation and retinoblastoma protein inactivation. We also determine a functional link between MT4-MMP and the growth factor receptor EGFR. Mechanistic experiments revealed direct association of MT4-MMP and its positive effects on EGFR phosphorylation in response to TGFα and EGF in cancer cells. Notably, the effects of MT4-MMP on proliferation and EGFR activation did not rely on metalloprotease activity. Clinically, MT4-MMP and EGFR expressions were correlated in human triple-negative breast cancer specimens. Altogether, our results identify MT4-MMP as a positive modifier of EGFR outside-in signaling that acts to cooperatively drive cancer cell proliferation.
Medical subject headings
- Breast Neoplasms
- Cell Membrane
- ErbB Receptors
- Matrix Metalloproteinases, Membrane-Associated
- Signal Transduction